Astrana Health, Inc. (ASTH)

Market Cap	2.66B
Revenue (ttm)	1.45B
Net Income (ttm)	62.42M
Shares Out	50.99M
EPS (ttm)	1.32
PE Ratio	39.55
Forward PE	34.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	230,452
Open	53.00
Previous Close	52.48
Day's Range	51.47 - 54.27
52-Week Range	28.87 - 54.27
Beta	1.16
Analysts	Strong Buy
Price Target	50.67 (-2.93%)
Earnings Date	Aug 7, 2024

About ASTH

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care phys...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 1,800
• Stock Exchange: NASDAQ
• Ticker Symbol: ASTH

Financial Performance

In 2023, Astrana Health's revenue was $1.39 billion, an increase of 21.19% compared to the previous year's $1.14 billion. Earnings were $60.72 million, an increase of 34.42%.

Analyst Forecast

According to 3 analysts, the average rating for ASTH stock is "Strong Buy." The 12-month stock price forecast is $50.67, which is a decrease of -2.93% from the latest price.

Price Target

$50.67

(-2.93% downside)

Analyst Consensus: Strong Buy